CORPORATE PROFILE

Nexeon is a bioelectronics company that has established a proven, disruptive model for identifying, funding, managing, and accelerating game-changing ideas into profitable, clinical innovations. The Company has expertise in monetizing intellectual property and leveraing non-dilutive capital in a tax-optimized vehicle. 

Chief among Company assets is a number of patents relating to a micro-perforated balloon catheter system for use in the treatment of restenosis associated with hemodialysis. Initially, the Company will focus on driving development and commercialization of the aforementioned medical device. Nexeon also has ownership interest in various R&D programs and other companies that are currently developing medical devices in neuromodulation, cardiology, and urology spaces. 

FREQUENTLY ASKED QUESTIONS

When was Nexeon formed?

December 7, 2015

When did Nexeon common stock start trading publicly? Or when will it?

Following SEC and FINRA Approval

Who is Nexeon's independent auditor?

Paritz & Company P.A.

When does Nexeon’s fiscal year end?

December 31

How are Nexeon’s shares traded?   

Upon Approval of SEC and FINRA, the Company will trade on the OTC Markets QB Exchange

Does Nexeon pay dividends?

No

Who is Nexeon’s transfer agent?

Action Stock Transfer Company

How do I transfer stock, change address on my shareholder account, or replace a lost stock certificate?   

Provide Link to Transfer Company Website www.actionstocktransfer.com

Does Nexeon have a direct stock purchase plan?  

No

How can I purchase Nexeon shares?  

Through your Registered Broker Dealer

When and where is Nexeon’s Annual Stockholder Meeting?   

Location is Lexington, KY; date of 2017 Annual Meeting is not yet determined